Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth
Jun Chen(Tianjin Medical University General Hospital), Shi‐Chung Ng(Ligand Pharmaceuticals (United States)), Wei Wu(China Agricultural University), Maryla Krajewska(Sanford Burnham Prebys Medical Discovery Institute), Paul E. Kroeger(Abbott (United States)), John C. Reed(Sanford Burnham Prebys Medical Discovery Institute), Stephen K. Tahir(Abbott Fund), Kate Welsh(Ionis Pharmaceuticals (United States)), Saul H. Rosenberg(AbbVie (United States)), Lex M. Cowsert(Ionis Pharmaceuticals (United States)), Frank Bennett(Ionis Pharmaceuticals (United States)), Stanisław Krajewski(Sanford Burnham Prebys Medical Discovery Institute)
Cited by 212
Related Papers
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
IAP family proteins---suppressors of apoptosis
|Genes & Development|1999|2.5k
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
|Cancer Research|2008|2k